Chonluten
ExperimentalKhavinson lung bioregulator / researchExperimental
Short peptide sold as a bronchial/lung bioregulator (Khavinson series). Not FDA-approved.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- Bronchial epithelium (proposed)
Overview
Short peptide sold as a bronchial/lung bioregulator (Khavinson series). Not FDA-approved.
Protocol
- Dosage Range
- Vendor research protocols only
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
Science
Mechanism of Action
Claimed to normalize bronchial epithelium gene expression in older Russian papers. Not established in modern RCTs.
Targets
Bronchial epithelium (proposed)
Studies
- Khavinson bioregulators— Journal/year not available
Benefits
Respiratory-bioregulator research category
Potential Side Effects
- Not characterized
References
- PMID 15587334External link · Year —